Lillian Siu
机构: Princess Margaret Cancer Centre
每年引用次数
引用次数
引用: 43,648
H-指数: 106
I10-指数 : 427
出版物: 1,049
A cost‐effectiveness analysis of human papillomavirus vaccination of boys for the prevention of oropharyngeal cancer
Donna M. Graham , Wanrudee Isaranuwatchai , Steven Habbous , Claire de Oliveira
Cancer 121 ( 11) 1785 -1792
44
2015
Abstract CT124: Sitravatinib and nivolumab in oral cavity cancer window of opportunity study (SNOW)
Marc Oliva Bernal , Douglas Chepeha , Amy Prawira , Douglass Vines
Cancer Research 79
2
2019
Abstract LB-230: A prospective clinical trial to evaluate DNA sequencing as a diagnostic tool to guide cancer therapy: results from the initial 50 patients
Andrew MK Brown , Philippe L Bedard , Ben Tran , Janet Dancey
Cancer Research 72
2012
Abstract SY16-01: Clinical trial design to match patients to treatment based on molecular profiling of tumors
Lillian L. Siu
Cancer Research 72
2012
Predictive and Pharmacodynamic Biomarker Studies in Tumor and Skin Tissue Samples of Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Treated With Erlotinib
Mark Agulnik , Gilda da Cunha Santos , David Hedley , Trudey Nicklee
Journal of Clinical Oncology 25 ( 16) 2184 -2190
94
2007
Phase I/II Trial of Erlotinib and Cisplatin in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: A Princess Margaret Hospital Phase II Consortium and National Cancer Institute of Canada Clinical Trials Group Study
Lillian L. Siu , Denis Soulieres , Eric X. Chen , Gregory R. Pond
Journal of Clinical Oncology 25 ( 16) 2178 -2183
127
2007
Surrogate End Points for Median Overall Survival in Metastatic Colorectal Cancer: Literature-Based Analysis From 39 Randomized Controlled Trials of First-Line Chemotherapy
Patricia A. Tang , Søren M. Bentzen , Eric X. Chen , Lillian L. Siu
Journal of Clinical Oncology 25 ( 29) 4562 -4568
200
2007
Combining Gemcitabine and Capecitabine in Patients With Advanced Biliary Cancer: A Phase II Trial
Jennifer J. Knox , David Hedley , Amit Oza , Ron Feld
Journal of Clinical Oncology 23 ( 10) 2332 -2338
259
2005
Molecularly Targeted Oncology Therapeutics and Prolongation of the QT Interval
Elizabeth L. Strevel , Douglas J. Ing , Lillian L. Siu
Journal of Clinical Oncology 25 ( 22) 3362 -3371
245
2007
Phase II Trial of Sorafenib in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck or Nasopharyngeal Carcinoma
Christine Elser , Lillian L. Siu , Eric Winquist , Mark Agulnik
Journal of Clinical Oncology 25 ( 24) 3766 -3773
182
2007
Randomized phase II trials: inevitable or inadvisable?
Hui K. Gan , Axel Grothey , Gregory R. Pond , Malcolm J. Moore
Journal of Clinical Oncology 28 ( 15) 2641 -2647
60
2010
Pretreatment neurocognitive function and self-reported symptoms in patients with newly diagnosed head and neck cancer compared with noncancer cohort
Lillian L. Siu , Albiruni R. Abdul Razak , Lori J. Bernstein , Gregory R. Pond
Head & Neck 40 ( 9) 2029 -2042
10
2018
Early phase clinical trials to identify optimal dosing and safety
Natalie Cook , Aaron R. Hansen , Lillian L. Siu , Albiruni R. Abdul Razak
Molecular Oncology 9 ( 5) 997 -1007
45
2015
Pre-clinical characterization of Dacomitinib (PF-00299804), an irreversible pan-ErbB inhibitor, combined with ionizing radiation for head and neck squamous cell carcinoma.
Justin P. Williams , Inki Kim , Emma Ito , Wei Shi
PLOS ONE 9 ( 5)
9
2014
Sucralfate mouthwash for prevention and treatment of 5-fluorouracil-induced mucositis: a randomized, placebo-controlled trial.
Michelle Nottage , Sue-Anne McLachlan , Mary-Anne Brittain , Amit Oza
Supportive Care in Cancer 11 ( 1) 41 -47
40
2003
The impact of an educational DVD on cancer patients considering participation in a phase I clinical trial
Elizabeth L. Strevel , Colin Newman , Gregory R. Pond , Martha MacLean
Supportive Care in Cancer 15 ( 7) 829 -840
29
2007
The Cisplatin Total Dose and Concomitant Radiation in Locoregionally Advanced Head and Neck Cancer: Any Recent Evidence for Dose Efficacy?
Lindsay Carlsson , Scott V. Bratman , Lillian L. Siu , Anna Spreafico
Current Treatment Options in Oncology 18 ( 7) 39
6
2017
Circulating tumor DNA and liquid biopsy in oncology
David W. Cescon , Scott V. Bratman , Steven M. Chan , Lillian L. Siu
Nature Reviews Cancer 1 ( 3) 276 -290
241
2020
Personalized circulating tumor DNA analysis as a predictive biomarker in solid tumor patients treated with pembrolizumab
Scott V. Bratman , S. Y. Cindy Yang , Marco A. J. Iafolla , Zhihui Liu
Nature Cancer 1 ( 9) 873 -881
26
2020
The contents and readability of informed consent forms for oncology clinical trials.
Winson Y. Cheung , Gregory R. Pond , Ronald J. Heslegrave , Katherine Enright
American Journal of Clinical Oncology 33 ( 4) 387 -392
21
2010